We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

1 hedge funds and large institutions have $12K invested in Antares Pharma, Inc. in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 172 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 177 → 1 (-176)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $375M → $12K (-$375M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 172

Holders
1
Holders Change
-176
Holders Change %
-99.44%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
172
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$49M
2
RCMNY
Rubric Capital Management (New York)
New York
-$44.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$35.4M
4
SIG
Sargent Investment Group
Maryland
-$15M
5
State Street
State Street
Massachusetts
-$14.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
– -$2.71M -660,601 Closed
Morgan Stanley
27
Morgan Stanley
New York
– -$2.54M -620,001 Closed
State Board of Administration of Florida Retirement System
28
State Board of Administration of Florida Retirement System
Florida
– -$2.5M -608,519 Closed
Two Sigma Advisers
29
Two Sigma Advisers
New York
– -$2.36M -574,732 Closed
LFCM
30
Long Focus Capital Management
Puerto Rico
– -$2.21M -540,000 Closed
PCM
31
Perkins Capital Management
Minnesota
– -$1.97M -481,483 Closed
Millennium Management
32
Millennium Management
New York
– -$1.92M -468,455 Closed
Citadel Advisors
33
Citadel Advisors
Florida
– -$1.84M -448,691 Closed
Boston Partners
34
Boston Partners
Massachusetts
– -$1.73M -420,620 Closed
AQR Capital Management
35
AQR Capital Management
Connecticut
– -$1.68M -409,037 Closed
Swiss National Bank
36
Swiss National Bank
Switzerland
– -$1.57M -382,000 Closed
MF
37
Magnetar Financial
Illinois
– -$1.54M -375,546 Closed
OAM
38
Oberweis Asset Management
Illinois
– -$1.41M -344,200 Closed
Ameriprise
39
Ameriprise
Minnesota
– -$1.29M -314,024 Closed
AC
40
Avenir Corporation
Virginia
– -$1.24M -302,852 Closed
Fidelity Investments
41
Fidelity Investments
Massachusetts
– -$1.2M -292,966 Closed
Marshall Wace
42
Marshall Wace
United Kingdom
– -$1.13M -275,284 Closed
William Blair & Company
43
William Blair & Company
Illinois
– -$1.13M -275,000 Closed
AG
44
Algert Global
California
– -$1.1M -268,478 Closed
First Trust Advisors
45
First Trust Advisors
Illinois
– -$1.07M -260,704 Closed
Baird Financial Group
46
Baird Financial Group
Wisconsin
– -$1.01M -245,801 Closed
Invesco
47
Invesco
Georgia
– -$993K -242,191 Closed
CC
48
Clearline Capital
New York
– -$987K -240,685 Closed
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
– -$976K -238,233 Closed
Renaissance Technologies
50
Renaissance Technologies
New York
– -$899K -219,328 Closed
1
2
3 4 5

ATRS Hedge Fund Activity: Q2 2022 in Review

1 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q2 2022, worth a combined $12K — down 100% from $375M a quarter earlier.

Sellers outnumbered buyers: 172 funds closed out of ATRS and 0 opened new positions — a net loss of 172 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $49M sold.

  • 1 institutional investor held Antares Pharma, Inc. (ATRS) as of Q2 2022, down from 177 in Q1 2022.
  • Funds reported $12K of Antares Pharma, Inc. stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Antares Pharma, Inc. positions in Q2 2022 and 172 closed out, a net change of -172 holders.
  • The largest Antares Pharma, Inc. seller in Q2 2022 was BlackRock, an estimated $49M sold.

Based on aggregated 13F filings for Q2 2022.